trial
as of 2026-07-01Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia
NCTId NCT02210962
at a glance
Phase 4 · Unknown
Enrollment 80 (estimated)
Sponsored by Medical University of Lodz
Primary completion 2015-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2011-09
Primary completion
2015-02
Eligibility
ALL · 16 Years · 35 Years
Interventions & indications
Sponsors
Medical University of LodzLead Sponsor
Investigators
1
Tomasz P Pawełczyk, MD, PhDPrincipal Investigator
Sites
1 total
Lodz, Poland
Facts & assertions
4 sourced
Enrollment
80
Phase
PHASE4
Primary Completion Date
2015-02
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator